Adverse events and tolerability of long-term  suppressive antibiotic therapy for periprosthetic  joint infection: a prospective cohort study

Reinecke, Pia; Karbysheva, Svetlana; Goumenos, Stavros; Conen, Anna; Pidgaiska, Olga; Perka, Carsten; Trampuz, Andrej; Khakzad, Thilo; Meller, Sebastian

doi:10.5194/jbji-11-267-2026

Articles | Volume 11, issue 3

https://doi.org/10.5194/jbji-11-267-2026

© Author(s) 2026. This work is distributed under
the Creative Commons Attribution 4.0 License.

https://doi.org/10.5194/jbji-11-267-2026

© Author(s) 2026. This work is distributed under
the Creative Commons Attribution 4.0 License.

Articles | Volume 11, issue 3

Original full-length article

|

12 May 2026

Original full-length article |

| 12 May 2026

Adverse events and tolerability of long-term suppressive antibiotic therapy for periprosthetic joint infection: a prospective cohort study

Pia Reinecke, Svetlana Karbysheva, Stavros Goumenos, Anna Conen, Olga Pidgaiska, Carsten Perka, Andrej Trampuz, Thilo Khakzad, and Sebastian Meller

Related authors

Malnutrition affects infection rates and quality of life in patients undergoing primary hip and knee arthroplasty: a retrospective study

Domenico De Mauro, Chiara Comisi, Valeria Maccauro, Giovanni Balato, Sebastian Meller, Martina Di Martino, Fabiana Arduini, Giulio Maccauro, and Raffaele Vitiello

J. Bone Joint Infect., 11, 139–147, https://doi.org/10.5194/jbji-11-139-2026,https://doi.org/10.5194/jbji-11-139-2026, 2026

Short summary

Prevalence, microbiological features, and risk factors for periprosthetic joint infections in oncologic patients following tumor resection and megaprosthetic reconstruction

Andreas G. Tsantes, Dimitrios V. Papadopoulos, Stavros Goumenos, Eleni Petrou, Ioannis G. Trikoupis, Anastasios Roustemis, Alexandra Mpakosi, Petros Ioannou, Christos Koutserimpas, Panayiotis Gavriil, Daniele Piovani, Stefanos Bonovas, Panayiotis J. Papagelopoulos, Athanasios Tsakris, and Argirios E. Tsantes

J. Bone Joint Infect., 10, 337–345, https://doi.org/10.5194/jbji-10-337-2025,https://doi.org/10.5194/jbji-10-337-2025, 2025

Short summary

Cited articles

Bindel, L. J. and Seifert, R.: Development of bacterial resistance in Germany from 2008 to 2022 – major culprit pathogens, antibacterial drugs, and prescribing practices, Naunyn. Schmiedebergs Arch. Pharmacol., 398, 4219–4236, https://doi.org/10.1007/s00210-024-03533-6, 2025.

Burr, R. G., Eikani, C. K., Adams, W. H., Hopkinson, W. J., and Brown, N. M.: Predictors of Success With Chronic Antibiotic Suppression for Prosthetic Joint Infections, J. Arthroplasty, 37, S983–s988, https://doi.org/10.1016/j.arth.2022.02.003, 2022.

Edwards, I. R. and Aronson, J. K.: Adverse drug reactions: definitions, diagnosis, and management, Lancet, 356, 1255–1259, https://doi.org/10.1016/s0140-6736(00)02799-9, 2000.

Escudero-Sánchez, R., Senneville, E., Digumber, M., Soriano, A., Del Toro, M. D., Bahamonde, A., Del Pozo, J. L., Guio, L., Murillo, O., Rico, A., García-País, M. J., Rodríguez-Pardo, D., Iribarren, J. A., Fernández, M., Benito, N., Fresco, G., Muriel, A., Ariza, J., and Cobo, J.: Suppressive antibiotic therapy in prosthetic joint infections: a multicentre cohort study, Clin. Microbiol. Infect., 26, 499–505, https://doi.org/10.1016/j.cmi.2019.09.007, 2020a.

Escudero-Sánchez, R., Ponce-Alonso, M., Barragán-Prada, H., Morosini, M. I., Cantón, R., Cobo, J., and Del Campo, R.: Long-Term Impact of Suppressive Antibiotic Therapy on Intestinal Microbiota, Genes, 12, https://doi.org/10.3390/genes12010041, 2020b.